EUVIMEDSkopri EUVIMED
Übersichtsarbeit

Left Bundle Branch Area Pacing in Congenital Heart Disease: Current Evidence, Challenges, and Future Directions

Reisuke Yoshizawa iD

Pacing and Clinical Electrophysiology · 2026-11 · 49 (11) · 1772-1781

DOI: 10.1111/pace.70402 ↗

At a glance

Übersichtsarbeit in Pacing and Clinical Electrophysiology, published online on 2026-08-19. Written by Reisuke Yoshizawa. Institution: Division of Cardiology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan. Major MEDLINE topics: Heart Defects, Congenital, Cardiac Pacing, Artificial, Bundle of His. 33 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Left bundle branch area pacing (LBBAP) has emerged as a promising alternative to right ventricular apical pacing in patients with congenital heart disease (CHD), yet its application in this population remains underexplored despite unique anatomical and physiological challenges. This review synthesizes current evidence on LBBAP in CHD, including anatomical considerations of the conduction system, lead selection between lumenless and stylet‐driven leads, technical modifications for different substrates, and clinical outcomes. In congenitally corrected transposition of the great arteries (CCTGA), the paradoxically anterior conduction system creates favorable anatomy for LBBAP, with reported success rates of 86%–100% in small observational series. CHD‐specific data from Moore et al. demonstrated superior QRS narrowing with conduction system pacing (CSP) compared to conventional CRT (35 vs. 14 ms; p = 0.04). One randomized trial and multiple meta‐analyses comparing lumenless and stylet‐driven leads demonstrate comparable success rates but distinct safety profiles, with implications for lead choice in CHD patients requiring lifelong pacing. The 2023 HRS/APHRS/LAHRS and 2025 ACC/AHA guidelines now recognize CSP as a therapeutic option in selected patients, though these endorsements are not specific to LBBAP in CHD. CHD‐specific evidence remains limited to case series and small observational studies. This review provides a practical framework for patient selection, lead choice, and procedural planning while identifying key research priorities for this growing patient population.

Subjects

MeSH terms (MEDLINE)

Heart Defects, CongenitalCardiac Pacing, ArtificialBundle of HisHumans

Author keywords

cardiac resynchronization therapyconduction system pacingcongenital heart diseasecongenitally corrected transpositionleft bundle branch area pacinglumenless leadsstylet‐driven leadssystemic right ventricle

Authors and institutions

  • Division of Cardiology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan.

ORCID profiles: Reisuke Yoshizawa

Cite

APA

Yoshizawa, R. (2026). Left Bundle Branch Area Pacing in Congenital Heart Disease: Current Evidence, Challenges, and Future Directions. Pacing and Clinical Electrophysiology, 49(11), 1772-1781. https://doi.org/10.1111/pace.70402

Vancouver

Yoshizawa R. Left Bundle Branch Area Pacing in Congenital Heart Disease: Current Evidence, Challenges, and Future Directions. Pacing and Clinical Electrophysiology. 2026;49(11):1772-1781. doi:10.1111/pace.70402

BibTeX
@article{Yoshizawa2026,
  author = {Yoshizawa, Reisuke},
  title = {Left Bundle Branch Area Pacing in Congenital Heart Disease: Current Evidence, Challenges, and Future Directions},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2026},
  volume = {49},
  number = {11},
  pages = {1772--1781},
  doi = {10.1111/pace.70402}
}
Start for free →